Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines

Journal of Immunology

Volumn 167, Issue 8, 2001, Pages 4574-4584

  Mordue, D G ^a   Monroy, F ^a   La Regina, M ^a   Dinarello, C A ^a   Sibley, L D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY BURDEN; CELL DEGENERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; GENOTYPE; GROWTH RATE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSTIMULATION; INFECTION PREVENTION; LETHALITY; LIVER INJURY; LYMPHOID CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE; SURVIVAL; TH1 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS; VIRULENCE;

EID: 0035887943     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.8.4574     Document Type: Article

References (63)

1. Pathophysiology of toxoplasmosis
2. Structures of Toxoplasma gondii tachyzoites, bradyzoites and sporozoites and biology and development of tissue cysts
3. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome
4. Toxoplasmosis in pregnancy
5. Virulent strains of Toxoplasma gondii comprise a single clonal lineage
6. Acute virulence in mice is associated with markers on chromosome VIII in Toxoplasma gondii
7. Toxoplasma gondii comprises three clonal lineages: Correlation of parasite genotype with human disease
8. Influence of genes within the MHC on mortality and brain cyst development in mice infected with Toxoplasma gondii: Kinetics of immune regulation in BALB H-2 congenic mice
9. + T cells determine cyst number in Toxoplasma gondii infection
10. Genetic regulation of early survival and cyst number after peroral Toxoplasma gondii infection of AXB/BXA recombinant inbred and congenic mice
11. Phenotypes and functions of lymphocytes in congenital toxoplasmosis
12. Isoenzyme analysis of 35 Toxoplasma gondii isolates: Biological and epidemiological implications
13. Genotypic characterization of Toxoplasmna gondii strains associated with human toxoplasmosis in Spain: Direct analysis from clinical samples
14. Determination of genotypes of Toxoplasma gondii strains isolated from patients with toxoplasmosis
15. Rapid identification of virulent type I strains of the protozoan parasite Toxoplasma gondii by PCR-restriction fragment length polymorphism analysis of the BI gene
16. Cyst rupture as a pathogenic mechanism of toxoplasmic encephalitis
17. Ocular toxoplasmosis: New directions for clinical investigation
18. Ocular toxoplasmosis in the fetus: Immunohistochemistry analysis and DNA amplification
19. Pathogenesis of toxoplasmic retinochoroiditis
20. Septic shock due to toxoplasmosis in patients infected with the human immunodeficiency virus
21. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient mice
22. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistance during acute infection with Toxoplasma gondii
23. Studies on the role of interleukin-12 in acute murine toxoplasmosis
24. Interferon-γ receptor-deficiency renders mice highly susceptible to toxoplasmosis by decreased macrophage activation
25. Interferon-γ: The major mediator of resistance against Toxoplasma gondii
26. Effector cells of both nonhemopoietic and hemopoietic origin are required for interferon (IFN)-γ- and tumor necrosis factor (TNF)-α-dependent host resistance to the intracellular pathogen Toxoplasma gondii
27. In vivo microbial stimulation induces rapid CD40 ligand-independent production of interleukin 12 by dendritic cells and their redistribution to T cell areas
28. Human polymorphonuclear leukocytes produce IL-12, TNF-α, and the chemokines macrophage-inflammatory protein-1α and -1β in response to Toxoplasma gondii antigens
29. In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection
30. A protective role for endogenous tumor necrosis factor in Toxoplasma gondii infection
31. Crucial role of TNF receptor type I (p55), but not of TNF receptor type 2 (p75), in murine toxoplasmosis
32. Acute cerebral toxoplasmosis is induced by in vivo neutralization of TNF-α and correlates with the down-regulated expression of inducible nitric oxide synthase and other markers of macrophage activation
33. Decreased resistance of TNF receptor p55 and p75 deficient mice to chronic toxoplasmosis despite normal activation of inducible nitric oxide synthase in vivo
34. Invasion of Toxoplasma gondii occurs by active penetration of the host cell
35. Toxoplasmic encephalitis in children
36. Strain-specific antigens of Toxoplasma gondii
37. Toxoplasma gondii: Isolation and preliminary characterization of temperature sensitive mutants
38. Interleukin-18 regulation of interferon-γ production and cell proliferation as shown in interleukin-1β converting enzyme (caspace-I)-deficient mice
39. Actin in Toxoplasma gondii is encoded by a single-copy gene, ACT1 and exists primarily in a globular form
40. Monoclonal antibodies to murine γ-interferon which differentially modulate macrophage activation and antiviral activity
41. Toxoplasma gondii-infected cells are resistant to multiple inducers of apoptosis
42. + T cell unresponsiveness during acute Toxoplasma gondii infection in mice
43. Prevention of lymphocyte cell death in sepsis improves survival in mice
44. Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis
45. + T cell-dependent, interferon-γ-mediated necrosis of the small intestine with genetic susceptibility of mice to peroral infection with Toxoplasma gondii
46. TNFα, nitric oxide and IFN-γ are all critical for development of necrosis in the small intestine and early mortality in genetically susceptible mice infected perorally with Toxoplasma gondii
47. + T cells and accompanied by overproduction of IL-12, IFN-γ, and TNF-α
48. Proinflammatory effects of IL-10 during human endotoxemia
49. IFN-γ-dependent and -independent mechanisms in adverse effects caused by concomitant administration of IL-18 and IL-12
50. Coadministration of interleukin-18 and interleukin-12 induces a fatal inflammatory response in mice: Critical role of natural killer cell interferon-γ production and STAT-mediated signal transduction
51. The role of IL-18 in innate immunity
52. IL-18: A Th 1-inducing proinflammatory cytokine and new member of the IL-1 family
53. IL-18 (IFN-γ inducing factor) regulates early cytokine production in, and promotes resolution of bacterial infection in mice
54. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-γ production
55. Neutralization of IL-18 reduces neutrophil tissue accumulation and protects mice against lethal Escherichia coli and Salmonella typhimurium endotoxemia
56. Endotoxin, Toll-like receptor 4 and the afferent limb of innate immunity
57. Interleukin-18 (IL-18) enhances innate IL-12-mediated resistance to Toxoplasma gondii
58. Caspase-1 activation of IL-1β and IL-18 are essential for Shigella flexneri-induced inflammation
59. Caspase-1-independent Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice
60. Isolation, structure elucidation and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma acting at picomolar concentration
61. Danger signals: SOS to the immune system
62. IFN-γ overproduction and high-level apoptosis are associated with high but not low virulence Toxoplasma gondii infection